Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Clinical trial NCT00135356 · COMPLETED

Trial details

NCT number: NCT00135356
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-Associated Lipodystrophy Syndrome

Start date: 2005-07-01
Primary completion: 2007-07-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.